EGS-18218-87782
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 335 / FL
- Registered
- 2021-12-12
- Relationship
- Child or adolescent in my care
- Guardian
- ELW-31422-14150
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-17
Dose 1 — Pfizer-BioNTech
-
2021-12-12
Registered in v-safe
-
2021-12-12
Dose 2 — Pfizer-BioNTech
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
-
2021-12-17
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Cough, Wheezing — Feeling: Poor · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Coughing and weezingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-18
- 2021-12-21
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
- 2022-01-23
- 2022-03-13
- 2022-06-12
- 2022-12-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-17 | Pfizer-BioNTech | No |
| 2 | 2021-12-12 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Coughing and weezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release